| Date | Title | Description |
| 02.07.2026 | Biotech and Food companies strengthen management teams on the business side |
Basel-based pharma company Idorsia has appointed Roland Wandeler as CEO, effective October 1, 2026. He will succeed Jean-Paul Clozel, who has been serving as ad interim CEO since March 2026 and will continue as Chairman of the Board of Dir... |
| 17.04.2026 | World Hemophilia Day 2026 - April 17, 2026 - "Diagnosis: First step to care." | MONTREAL, April 17, 2026 /PRNewswire/ -- On April 17, 2026, the global inherited bleeding disorders community will come together on World Hemophilia Day to advocate for all inherited bleeding disorders. This year's theme of "Diagnosis:... |
| 23.06.2025 | Grifols Case Shows It Paid Family-Linked Entity More for Plasma | - |
| 19.05.2025 | Envoke Raises Further £1M | Envoke, a Leeds, UK-based provider of simulator software for lab equipment, raised £1m in funding.
NPIF – Mercia Equity Finance, which is managed by Mercia and is part of the Northern Powerhouse Investment Fund, invested £500k matched by £5... |
| 19.05.2025 | British HealthTech startup Envoke raises further €1.1 million to develop “flight simulator for lab equipment” | Leeds-based Envoke, a HealthTech startup developing simulation software that enables medical staff to train to use laboratory equipment and troubleshoot problems, has raised an additional €1.1 million.
NPIF – Mercia Equity Finance, which is... |
| 25.04.2025 | A Lifeline for Hemophilia: Sanofi and Sobi's Renewed Commitment to Global Health | In a world where access to healthcare can be as elusive as a mirage, the partnership between Sanofi, Sobi, and the World Federation of Hemophilia (WFH) stands as a beacon of hope. On April 25, 2025, these organizations announced a significa... |
| 25.04.2025 | Sanofi and Sobi extend their partnership with the World Federation of Hemophilia Humanitarian Aid Program | Up to five-year contract extension to support the WFH Humanitarian Aid Program with medicine donations and financial assistance
MONTREAL, April 25, 2025 /PRNewswire/ -- The World Federation of Hemophilia (WFH) and WFH USA, together with San... |
| 25.04.2025 | Sobi and Sanofi’s Foundation S extend partnership with the World Federation of Hemophilia Humanitarian Aid Program | Sobi and Sanofi’s Foundation S extend partnership with the World Federation of Hemophilia Humanitarian Aid Program
Fri, Apr 25, 2025 06:00 CET Report this content
Up to five-year contract extension to support the WFH Humanitarian Aid Progra... |
| 17.04.2025 | World Hemophilia Day 2025 - April 17, 2025 - "Access for all: Women and girls bleed too" | MONTREAL, April 17, 2025 /PRNewswire/ -- On April 17, 2025, the global bleeding disorders community will come together under the theme "Access for all: Women and girls bleed too" and celebrate World Hemophilia Day. Today, women an... |
| 23.12.2024 | Netherlands Based GenAI Bitotech Startup Cradle Raises $73M in Series B Round An Uber and Netflix VC backer invests. | Written by Akriti Seth
Cradle, a Netherlands-based generative artificial intelligence (genAI) biotech startup, has raised $73 million in a Series B funding round.
The round was led by Silicon valley VC firm IVP, which is famous for backing ... |
| 29.11.2024 | Cradle Secures $73M to Revolutionize Planetary Health with AI-Driven Protein Engineering | AI biotech company Cradle has raised $73 million in a Series B funding round led by IVP and backed by Index Ventures and Kindred Capital, bringing its total funding to over $100 million.
Based in Amsterdam, the Netherlands, and Zurich, Swit... |
| 27.11.2024 | Cradle's Bold Leap: Revolutionizing Protein Engineering with AI | In the world of biotechnology, the race to innovate is relentless. At the forefront of this race is Cradle, a trailblazing company based in Amsterdam. Recently, Cradle secured a whopping $73 million in Series B funding, pushing its total fu... |
| 26.11.2024 | Cradle Raises $73M in Series B Funding | Cradle, an Amsterdam, the Netherlands-based provider of a platform for AI-powered protein engineering, raised $73M in Series B funding.
The round was led by IVP with participation from previous investors Index Ventures and Kindred Capital.
... |
| 26.11.2024 | Zurich-based Cradle raises €69.5 million to develop protein engineering with generative AI | Cradle, a Swiss platform for AI-powered protein engineering, has secured €69.5 million in a Series B funding round led by IVP, with participation from previous investors Index Ventures and Kindred Capital.
This investment brings Cradle’s to... |
| 25.06.2024 | Whatfix partners with Tech Mahindra to drive digital adoption | Whatfix, known for its digital adoption platforms, has entered a strategic collaboration with Tech Mahindra, a technology consulting and digital solutions provider. The collaboration aims to accelerate the adoption of data-driven digital so... |
| 20.06.2024 | Whatfix and Tech Mahindra Join Forces to Accelerate Adoption of Data-Driven Digital Solutions for Enterprises Globally | Bangalore, Karnataka, India
Whatfix, a global leader in digital adoption platforms (DAP), today announced a strategic collaboration with Tech Mahindra (NSE: TECHM), a leading global provider of technology consulting and digital solutions to... |
| 20.04.2024 | Grifols celebrates 50 years in Clayton | Grifols, a global manufacturer of plasma-based medicines headquartered in Barcelona, Spain, held a celebration to mark 50 years in Clayton, NC.
Grifols acquired the Johnston County facility in 2011 from Talecris Biotherapeutics, turning Gri... |
| 17.04.2024 | World Hemophilia Day 2024"Equitable access for all: recognizing all bleeding disorders" | MONTREAL, April 17, 2024 /PRNewswire/ -- On April 17, 2024, the global bleeding disorders community will come together to celebrate World Hemophilia Day. The theme of the event this year is "Equitable access for all: recognizing all bl... |
| 15.03.2024 | Hackensack Meridian Health CEO: These 4 Priorities Should Guide AI Strategy | During a keynote address this week at the HIMSS conference in Orlando, Hackensack Meridian Health CEO Robert Garrett declared that AI “has the potential to build healthier communities on a scale and pace that was previously unimaginable.”
A... |
| 12.03.2024 | STD Diagnostics Market to Reach USD 16.06 Billion by 2030, Driven by Rising Incidence & Improved Screening Technologies | STD diagnostics Market
STD Diagnostics Market Analysis, Size, Share, Industry Trends and Growth Outlook AUSTIN, TEXAS, UNITED STATES, March 12, 2024 /EINPresswire.com/ -- The global sexually transmitted disease (STD) diagnostics market is p... |
| 08.03.2024 | Hepatitis Testing/Diagnosis Market is growing at a CAGR of 5% from 2024 to 2030 by Exactitude Consultancy | Hepatitis Testing/Diagnosis Market
The Exactitude Consultancy Hepatitis Testing/Diagnosis Market Report – Size, Trends, and Forecast 2024-2030
The demand for hepatitis testing/diagnosis is increasing due to rising awareness, prevalence of h... |
| 07.03.2024 | Blood Group Typing Market Expected to Reach USD 5.5 billion, Projected Growth at 8.8% CAGR by 2031- Transparency Market Research, Inc. | - |
| 16.02.2023 | Blood Biotech Grifols Cuts Deep in the U.S. to Find €400M in Savings | Grifols, a company that turns blood plasma into therapies for immunological disorders and other conditions, is laying off about 2,000 U.S. workers as part of a corporate restructuring projected to yield up to €400 million in annual cost sav... |
| 26.01.2022 | Grifols S A : January 26, 2022Grifols maintains its standing in the Bloomberg Gender-Equality Index for its commitment to equality | Grifols maintains its standing in the
Bloomberg Gender-Equality Index for its
commitment to equality
For the second consecutive year, Grifols is part of the Bloomberg Gender- Equality Index (GEI), reaffirming its commitment to equality, fem... |
| 26.01.2022 | Grifols S A : maintains its standing in the Bloomberg Gender-Equality Index for its commitment to equality | January 26, 2022 Grifols maintains its standing in the Bloomberg Gender-Equality Index for its commitment to equality
Print this news Download the press release
For the second consecutive year, Grifols is part of the Bloomberg Gender-Equali... |
| 26.01.2022 | Grifols S A : achieves a high level of acceptance of its PTO to Biotest and advances on its strategic transaction | January 26, 2022 Grifols achieves a high level of acceptance of its PTO to Biotest and advances on its strategic transaction
Print this news Download the press release
At the end of the Public Takeover Offer (PTO) acceptance period to Biote... |
| 26.01.2022 | Grifols S A : January 26, 2022Grifols achieves a high level of acceptance of its PTO to Biotest and advances on its strategic transaction | Grifols achieves a high level of acceptance of
its PTO to Biotest and advances on its
strategic transaction
At the end of the Public Takeover Offer (PTO) acceptance period to Biotest's shares, Grifols exceeds the 96% of voting rights and ho... |
| 02.12.2021 | Grifols S A : receives first certifications for new In Vitro Diagnostics Medical Devices European Regulation | December 2, 2021 Grifols receives first certifications for new In Vitro Diagnostics Medical Devices European Regulation
Print this news Download the press release
Initial certifications obtained for broad product range including Promonitor ... |
| 24.11.2021 | Grifols S A : launches new home-care treatment service for patients with alpha-1 antitrypsin deficiency in Spain | November 24, 2021 Grifols launches new home-care treatment service for patients with alpha-1 antitrypsin deficiency in Spain
Print this news Download the press release
The new service will include the administration of the intravenous treat... |
| 17.11.2021 | Grifols S A : November 17, 2021Grifols and GIC obtain authorization for their strategic agreement for USD 1 billion | Grifols and GIC obtain authorization for their
strategic agreement for USD 1 billion
The Singaporean sovereign wealth fund (GIC) becomes a strategic investor by investing USD 1 billion to acquire a minority stake in Biomat USA, a Grifols su... |
| 17.11.2021 | Grifols S A : and GIC obtain authorization for their strategic agreement for USD 1 billion | November 17, 2021 Grifols and GIC obtain authorization for their strategic agreement for USD 1 billion
Print this news Download the press release
The Singaporean sovereign wealth fund (GIC) becomes a strategic investor by investing USD 1 bi... |
| 15.11.2021 | Grifols S A : November 15, 2021Grifols is included on the Dow Jones Sustainability World Index | Grifols is included on the Dow Jones
Sustainability World Index and
advances as one of the world's most
sustainable companies
For the first time ever, Grifols has been included on the Dow Jones Sustainability World Index (DJSI World) while ... |
| 15.11.2021 | Grifols S A : is included on the Dow Jones Sustainability World Index | November 15, 2021 Grifols is included on the Dow Jones Sustainability World Index
Print this news Download the press release
For the first time ever, Grifols has been included on the Dow Jones Sustainability World Index (DJSI World) while r... |
| 11.11.2021 | Grifols advances on the execution of its strategic plan | November 11, 2021 Grifols advances on the execution of its strategic plan
Print this news Download the press release
Biotest AG's Management Board and Supervisory Board endorse Grifols' investment and recommend minority shareholders to acce... |
| 26.10.2021 | Grifols S A : earns approval for the voluntary public tender offer of Biotest and advances its strategy to increase the availability of plasma-derived medicines | October 26, 2021 Grifols earns approval for the voluntary public tender offer of Biotest and advances its strategy to increase the availability of plasma-derived medicines
Print this news Download the press release
The German Federal Financ... |
| 26.10.2021 | Grifols S A : October 26, 2021Grifols earns approval for the voluntary public tender offer of Biotest and advances its strategy to increase the availability of plasma-derived medicines | Grifols earns approval for the voluntary public tender offer of Biotest and advances its strategy to increase the availability of plasma-derived medicines
The German Federal Financial Supervisory Authority, the Bundesanstalt für Finanzdiens... |
| 13.10.2021 | Grifols S A : increases access to plasma-derived therapies as part of its commitment to donors and patients | October 13, 2021 Grifols increases access to plasma-derived therapies as part of its commitment to donors and patients
Print this news Download the press release
For the month of October, Grifols supports International Plasma Awareness Week... |
| 13.10.2021 | Grifols S A : October 13, 2021Grifols increases access to plasma-derived therapies as part of its commitment to donors and patients | Grifols increases access to plasma-derived
therapies as part of its commitment to
donors and patients
For the month of October, Grifols supports International Plasma Awareness Week (IPAW), an initiative organized by the Plasma Protein Thera... |
| 05.10.2021 | Grifols S A : October 5, 2021Grifols closes its EUR 2 billion bond issuance to finance its investment in Biotest | Grifols closes its EUR 2 billion bond issuance
to finance its investment in Biotest
The issuance, launched on September 27, 2021, has been closed in record time following the positive reaction of financial investors
Investors recognize Grif... |
| 05.10.2021 | Grifols S A : closes its EUR 2 billion bond issuance to finance its investment in Biotest | October 5, 2021 Grifols closes its EUR 2 billion bond issuance to finance its investment in Biotest
Print this news Download the press release
The issuance, launched on September 27, 2021, has been closed in record time following the positi... |
| 05.10.2021 | Grifols, S.A. Closes the Issuance of Senior Unsecured Notes in the Equivalent Amount of EUR 2 Billion to Finance Its Investment in Biotest AG | As a continuation of the Other Relevant Information communication ("OIR") filed by Grifols on 27 September 2021, Grifols informed that it has closed the issuance of its Senior Unsecured Notes in the equivalent amount of EUR 2 bill... |
| 28.09.2021 | Grifols S A : begins commercializing TAVLESSE® in France, Italy and Spain to treat chronic immune thrombocytopenia | September 28, 2021 Grifols begins commercializing TAVLESSE® in France, Italy and Spain to treat chronic immune thrombocytopenia
Print this news Download the press release
TAVLESSE® (fostamatinib) is indicated for the treatment of chronic im... |
| 17.09.2021 | Grifols S A : announces its investment in Biotest | Grifols acquires Tiancheng Pharmaceutical Holdings, the largest shareholder of Biotest, to increase patients' access to plasma therapies
Grifols agrees to acquire the existing share capital of Tiancheng (Germany) Pharmaceutical Holdings for... |
| 16.08.2021 | Grifols S A : August 16, 2021Grifols advances on its strategic investment from GIC with 90% of consents from its notes holders and lenders | Grifols advances on its strategic investment from GIC with 90% of consents from its notes holders and lenders
Grifols closes the "Consent Solicitation" from Notes holders and lenders in record time.
The company has received consen... |
| 29.07.2021 | Grifols S A : The Bioscience Division grows 5.1% in the second quarter and raises first-half revenues to EUR 2,537 million | Free translation from the original in
Spanish. In the event of discrepancy, the
Spanish language version will prevail.
First Half 2021 Results
The Bioscience Division grows 5.1% in the second quarter and raises first-half revenues to EUR 2,... |
| 29.07.2021 | Grifols S A : 2021 first half earnings release | Free translation from the original in
Spanish. In the event of discrepancy, the
Spanish language version will prevail.
First Half 2021 Results
The Bioscience Division grows 5.1% in the second quarter and raises first-half revenues to EUR 2,... |
| 19.07.2021 | Grifols further expands its activity in Africa with agreement to set up an intravenous solutions manufacturing plant in Nigeria
USA - English France - Français | |
| 19.07.2021 | Grifols S A : further expands its activity in Africa with agreement to set up an intravenous solutions manufacturing plant in Nigeria | July 19, 2021 Grifols further expands its activity in Africa with agreement to set up an intravenous solutions manufacturing plant in Nigeria
Print this news Download the press release
To be constructed by Grifols Engineering, a global stan... |
| 14.07.2021 | Grifols S A : becomes official partner of UEFA Women's Football | July 14, 2021 Grifols becomes official partner of UEFA Women's Football
Print this news Download the press release
Grifols expands its support of women's athletic competitions and commitment to gender equality as women's football continues ... |
| 01.07.2021 | Grifols S A : announces a strategic investment from GIC of USD 1 billion | Barcelona -- Grifols (MCE:GRF, MCE:GRF.P, NASDAQ:GRFS), a global healthcare leader with a track record of more than 100 years dedicated to enhancing people's health and well-being and a forerunner in plasma-derived medicines, transfusion di... |
| 30.06.2021 | Grifols S A : June 30, 2021Grifols announces a strategic investment from GIC of USD 1 billion | Grifols announces a strategic investment from GIC of approximately USD 1 billion
GIC will invest approximately USD 1 billion to acquire a minority stake in Grifols' US subsidiary Biomat USA, which manages 296 U.S.-based plasma collection ce... |
| 25.06.2021 | Grifols S A : discloses transfers of value made to European healthcare professionals and healthcare organizations in 2020 | June 25, 2021 Grifols discloses transfers of value made to European healthcare professionals and healthcare organizations in 2020
Print this news Download the press release
The company has released voluntary disclosures since 2015 in accord... |
| 19.05.2021 | Grifols takes another step in the fight against Alzheimer's, partners with Ace to open first AMBAR® Center in Barcelona | |
| 19.05.2021 | GRIFOLS, S.A.
Grifols S A : takes another step in the fight against Alzheimer's, partners with Ace to open first AMBAR® Center in Barcelona | May 19, 2021 Grifols takes another step in the fight against Alzheimer's, partners with Ace to open first AMBAR® Center in Barcelona
Print this news Download the press release
The center will collect real-world data on AMBAR® clinical progr... |
| 15.04.2021 | Grifols Extends Commitment to World Federation of Hemophilia Humanitarian Aid Program to 2030 | |
| 23.02.2021 | Grifols PharmacyKeeper ranked No. 1 as 'Best in KLAS' for fifth consecutive year | |
| 16.12.2020 | Grifols S A : December 16, 2020Grifols creates a Sustainability Committee to strengthen its long-term sustainable growth model | Grifols creates a Sustainability Committee to strengthen its long-term sustainable growth model
Grifols bolsters its corporate governance structure, reinforcing its position as a responsible and transparent company committed to its stakehol... |
| 01.10.2020 | Grifols closes the acquisition of Green Cross fractionation plant in Canada and 11 plasma centers in the U.S. | |
| 01.04.2020 | Coronavirus Business Tracker: How The Private Sector Is Fighting The Covid-19 Pandemic | Alain Mérieux, founder of BioMérieux.AFP via Getty Images |
| 27.01.2014 | Part 1: Innovation In Barcelona | This article is based on interviews with changemakers, influencers and innovation practitioners: Joan Marti Estevez (Acc1o), Jorge Juan Fernandez (Biocat & Hospital Sant Joan de Déu), Sonia Mulero (Fundacion INLEA), Jesus Purroy (Parc C... |
| 15.06.2011 | Grifols crea el vehículo Gri-Cel para invertir en Bio-tech | 15/06/2011
GRIFOLS CREA EL VEHÍCULO GRI-CEL PARA INVERTIR EN BIO-TECH.
El fabricante de hemoderivados Grifols, ha creado la sociedad hólding Gri-Cel mediante la que agrupará las participaciones que tome en empresas que desarrollen su acti... |
| 01.06.2011 | Grifols and Talecris get FTC approval to merge | The FTC had been concerned that a merger of two of the top companies in the specialized blood therapeutics space would hurt competition and lead to higher drug costs for patients. The FTC raised antitrust concerns in 2009 when it blocked a ... |
| 02.05.2011 | Talecris-Grifols merger wins preliminary FTC approval | The consent agreement is still subject to approval by FTC commissioners. FTC officials had been concerned that the acquisition of Research Triangle Park, North Carolina-based Talecris would reduce competition and raise prices for drugs in t... |
| 11.04.2011 | Talecris-Grifols merger: investors showing growing confidence in the deal | The Talecris Biotherapeutics acquisition by Spanish company Grifols (MCE:GRF) looks like it’s moving closer to receiving regulatory approval, at least that’s how stock traders view the deal.
Bloomberg Businessweek reports that investors hav... |
| 13.02.2011 | Can blood therapy bear one less firm? Talecris, Grifols on brink of merger | Promoted
Covid-19’s terrible toll on diabetes patients. What can be done?
The public health crisis has undermined the economy and made people with chronic conditions more vulnerable and stressed. Learn more with a new report from Omada Heal... |
| - | Talecris-Grifols merger wins preliminary FTC approval | Talecris Biotherapeutics’ (NASDAQ:TLCR) $4 billion acquisition by Spanish company Grifols (MCE:GRF) looks like it will finally win regulatory approval.
Barcelona-based Grifols said Monday that it has reached a preliminary agreement with the... |
| - | Can blood therapy bear one less firm? Talecris, Grifols on brink of merger | On a day when lovers and spouses profess their love, Talecris Biotherapeutics shareholders will vote whether to bless the $3.4 billion marriage of their company to Spanish suitor Grifols.
Talecris (NASDAQ:TLCR) shareholders are gathering ne... |
| - | Talecris-Grifols merger: investors showing growing confidence in the deal | The Talecris Biotherapeutics acquisition by Spanish company Grifols (MCE:GRF) looks like it’s moving closer to receiving regulatory approval, at least that’s how stock traders view the deal.
Bloomberg Businessweek reports that investors hav... |
| - | Grifols and Talecris get FTC approval to merge | Grifols‘ (MCE:GRF) $4 billion acquisition of Talecris Biotherapeutics (NASDAQ:TLCR) now has the regulatory clearance to close.
Barcelona, Spain-based Grifols said Wednesday that the U.S. Federal Trade Commission has accepted a consent agree... |
